Literature DB >> 30972465

Good 5-year outcomes after arthroscopic treatment for femoroacetabular impingement syndrome.

Axel Öhlin1, Mattias Ahldén1, Ida Lindman1, Páll Jónasson2, Neel Desai1, Adad Baranto1, Olufemi R Ayeni3, Mikael Sansone4,5.   

Abstract

PURPOSE: The purpose of the present study was to evaluate the outcome of arthroscopic treatment for femoroacetabular impingement (FAI) syndrome 5 years post-surgery using patient-reported outcome scores (PROMs) validated for a young and active population with hip complaints.
METHODS: Patients were prospectively included in the study. A total of 184 patients [males = 110 (59.8%), females = 74 (40.2%)], with mean age 38.0, underwent arthroscopic treatment for FAI syndrome and were analysed. Preoperatively and at the 5-year follow-up, patients completed a set of self-administered web-based PROMs consisting of the International Hip Outcome Tool (iHOT-12), the Copenhagen Hip and Groin Outcome Score (HAGOS), the Hip Sports Activity Scale (HSAS), the EuroQoL-5 Dimension Questionnaire (EQ-5D), the EQ-Visual Analogue Scale (VAS) and the VAS for overall hip function and overall satisfaction. The Wilcoxon signed rank test was used to compare preoperative PROM values with those obtained at the 5-year follow-up.
RESULTS: A comparison of preoperative PROM scores and those obtained at the 5-year follow-up revealed statistically significant improvements for all outcome scores (p < 0.05), except for the HSAS score, which were unchanged; iHOT-12 (42.9 vs 67.2), HAGOS different subscales (50.2 vs 69.6, 55.7 vs 76.1, 59.2 vs 72.3, 41.1 vs 66.4, 30.8 vs 60.2, 31.6 vs 60.4), EQ-5D (0.570 vs 0.742), EQ-VAS (66.6 vs 74.4), HSAS (3.13 vs 3.17) and VAS for overall hip function (47.9 vs 69.2). At the 5-year follow-up, 154 patients reported that they were satisfied with surgery (84.6%). Survivorship at the 5-year follow-up was 86.4%.
CONCLUSION: Arthroscopic treatment for FAI syndrome yields good patient-reported outcome at the 5-year follow-up. LEVEL OF EVIDENCE: II.

Entities:  

Keywords:  FAI syndrome; Hip arthroscopy; Long term; Outcome

Year:  2019        PMID: 30972465     DOI: 10.1007/s00167-019-05429-y

Source DB:  PubMed          Journal:  Knee Surg Sports Traumatol Arthrosc        ISSN: 0942-2056            Impact factor:   4.342


  6 in total

1.  Correlation of the Single-Assessment Numeric Evaluation (SANE) Score With Hip-Specific Patient-Reported Outcome Measures.

Authors:  Guillaume D Dumont; Rachel L Glenn; Nicole C Battle; Zachary T Thier
Journal:  Arthrosc Sports Med Rehabil       Date:  2021-03-22

2.  Low rate of high-level athletes maintained a return to pre-injury sports two years after arthroscopic treatment for femoroacetabular impingement syndrome.

Authors:  Josefin Abrahamson; Ida Lindman; Mikael Sansone; Axel Öhlin; Pall Jonasson; Jón Karlsson; Adad Baranto
Journal:  J Exp Orthop       Date:  2020-06-25

3.  Arthroscopic Correction of Sports-Related Femoroacetabular Impingement in Competitive Athletes: 2-Year Clinical Outcome and Predictors for Achieving Minimal Clinically Important Difference.

Authors:  Karen Mullins; David Filan; Patrick Carton
Journal:  Orthop J Sports Med       Date:  2021-03-04

4.  Less hip range of motion is associated with a greater alpha angle in people with longstanding hip and groin pain.

Authors:  August Estberger; Anders Pålsson; Ioannis Kostogiannis; Eva Ageberg
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2021-09-12       Impact factor: 4.342

5.  Five-Year Follow-up After Hip Arthroscopic Surgery in the Horsens-Aarhus Femoroacetabular Impingement (HAFAI) Cohort.

Authors:  Signe Kierkegaard; Inger Mechlenburg; Ulrik Dalgas; Bent Lund
Journal:  Orthop J Sports Med       Date:  2022-03-08

6.  Five-Year Outcomes After Arthroscopic Surgery for Femoroacetabular Impingement Syndrome in Elite Athletes.

Authors:  Ida Lindman; Axel Öhlin; Neel Desai; Kristian Samuelsson; Olufemi R Ayeni; Eric Hamrin Senorski; Mikael Sansone
Journal:  Am J Sports Med       Date:  2020-03-20       Impact factor: 6.202

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.